{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:56:05Z","timestamp":1792684565123,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070877"],"award-info":[{"award-number":["82070877"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7222119"],"award-info":[{"award-number":["7222119"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2016-I2M-3\u2013007"],"award-info":[{"award-number":["2016-I2M-3\u2013007"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021\u20131-I2M-029"],"award-info":[{"award-number":["2021\u20131-I2M-029"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1\u2013005"],"award-info":[{"award-number":["2021-I2M-1\u2013005"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2022-I2M-JB-010"],"award-info":[{"award-number":["2022-I2M-JB-010"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.biopha.2023.115113","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T08:39:37Z","timestamp":1688632777000},"page":"115113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1\/AMPK signaling pathway"],"prefix":"10.1016","volume":"165","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meidai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9098-790X","authenticated-orcid":false,"given":"Guifen","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanhua","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2023.115113_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-017-0806-8","article-title":"Non-alcoholic fatty liver disease","volume":"15","author":"Neuschwander-Tetri","year":"2017","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.biopha.2023.115113_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2023.115113_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115113_bib4","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.biopha.2023.115113_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115113_bib6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115113_bib7","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1194\/jlr.R800018-JLR200","article-title":"Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis","volume":"49","author":"Yen","year":"2008","journal-title":"J. Lipid Res"},{"issue":"3","key":"10.1016\/j.biopha.2023.115113_bib8","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.biopha.2023.115113_bib9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.biopha.2023.115113_bib10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med"},{"issue":"6","key":"10.1016\/j.biopha.2023.115113_bib11","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s00394-017-1492-1","article-title":"Chronic consumption of fructose in combination with trans fatty acids but not with saturated fatty acids induces nonalcoholic steatohepatitis with fibrosis in rats","volume":"57","author":"Jeyapal","year":"2018","journal-title":"Eur. J. Nutr."},{"issue":"12","key":"10.1016\/j.biopha.2023.115113_bib12","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1002\/ptr.6486","article-title":"Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db\/db mice","volume":"33","author":"Yang","year":"2019","journal-title":"Phytother. Res"},{"issue":"10290","key":"10.1016\/j.biopha.2023.115113_bib13","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2023.115113_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.biopha.2023.115113_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3350\/cmh.2013.19.3.210","article-title":"Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis","volume":"19","author":"Koo","year":"2013","journal-title":"Clin. Mol. Hepatol."},{"issue":"36","key":"10.1016\/j.biopha.2023.115113_bib16","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.3748\/wjg.v23.i36.6549","article-title":"Treatment options for alcoholic and non-alcoholic fatty liver disease: A review","volume":"23","author":"Singh","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115113_bib17","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","article-title":"AMPK and SIRT1: a long-standing partnership","volume":"298","author":"Ruderman","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"34","key":"10.1016\/j.biopha.2023.115113_bib18","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.3748\/wjg.v25.i34.5120","article-title":"Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1\/AMPK and NF-\u03baB signaling pathways","volume":"25","author":"Li","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2023.115113_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fphar.2020.00216","article-title":"Hepatic Proteomic Changes and Sirt1\/AMPK Signaling Activation by Oxymatrine Treatment in Rats With Non-alcoholic Steatosis","volume":"11","author":"Xu","year":"2020","journal-title":"Front Pharm."},{"issue":"Suppl 5","key":"10.1016\/j.biopha.2023.115113_bib20","first-page":"201S","article-title":"Fatty acid metabolism, the central nervous system, and feeding","volume":"14","author":"Ronnett","year":"2006","journal-title":"Obes. (Silver Spring)"},{"issue":"1","key":"10.1016\/j.biopha.2023.115113_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1074\/jbc.M109.056762","article-title":"AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance","volume":"285","author":"Dzamko","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115113_bib22","first-page":"1","article-title":"Fish oil and chicoric acid combination protects better against palmitate-induced lipid accumulation via regulating AMPK-mediated SREBP-1\/FAS and PPAR\u03b1\/UCP2 pathways","author":"Mohammadi","year":"2020","journal-title":"Arch. Physiol. Biochem"},{"issue":"44","key":"10.1016\/j.biopha.2023.115113_bib23","doi-asserted-by":"crossref","first-page":"33959","DOI":"10.1074\/jbc.M110.122978","article-title":"SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism","volume":"285","author":"Ponugoti","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2023.115113_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128648","article-title":"Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet","volume":"10","author":"Sodhi","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2023.115113_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s13105-019-00678-4","article-title":"Hesperetin is a potent bioactivator that activates SIRT1-AMPK signaling pathway in HepG2 cells","volume":"75","author":"Shokri Afra","year":"2019","journal-title":"J. Physiol. Biochem"},{"issue":"4","key":"10.1016\/j.biopha.2023.115113_bib26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2174\/1871520616666160621105306","article-title":"Physico-chemical and Biological Evaluation of Flavonols: Fisetin, Quercetin and Kaempferol Alone and Incorporated in beta Cyclodextrins","volume":"17","author":"Corina","year":"2017","journal-title":"Anticancer Agents Med Chem."},{"issue":"1","key":"10.1016\/j.biopha.2023.115113_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/13880209.2021.1877734","article-title":"Kaempferol suppresses acetaminophen-induced liver damage by upregulation\/activation of SIRT1","volume":"59","author":"BinMowyna","year":"2021","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2023.115113_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106005","article-title":"Old wine in new bottles: Kaempferol is a promising agent for treating the trilogy of liver diseases","volume":"175","author":"Xiao","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2023.115113_bib29","article-title":"Mechanisms of Kaempferol in the treatment of diabetes: A comprehensive and latest review","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"16","key":"10.1016\/j.biopha.2023.115113_bib30","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.3390\/ijms22168847","article-title":"Kaempferol and Kaempferide Attenuate Oleic Acid-Induced Lipid Accumulation and Oxidative Stress in HepG2 Cells","volume":"22","author":"Tie","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2023.115113_bib31","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/clinchem\/27.12.2008","article-title":"Estimation of very-low-density lipoprotein cholesterol from data on triglyceride concentration in plasma","volume":"27","author":"Wilson","year":"1981","journal-title":"Clin. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2023.115113_bib32","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.biopha.2023.115113_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13622","article-title":"Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship","volume":"52","author":"Karkucinska-Wieckowska","year":"2022","journal-title":"Eur. J. Clin. Invest"},{"issue":"18","key":"10.1016\/j.biopha.2023.115113_bib34","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115113_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1016\/j.biopha.2023.115113_bib36","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.biopha.2023.115113_bib37","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1039\/C4FO00844H","article-title":"The anti-obesity and anti-diabetic effects of kaempferol glycosides from unripe soybean leaves in high-fat-diet mice","volume":"6","author":"Zang","year":"2015","journal-title":"Food Funct."},{"issue":"28","key":"10.1016\/j.biopha.2023.115113_bib38","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","article-title":"Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations","volume":"20","author":"Mili\u0107","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115113_bib39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s13679-019-00349-x","article-title":"Ethnic disparities in adiposity: focus on non-alcoholic fatty liver disease, visceral, and generalized obesity","volume":"8","author":"Agbim","year":"2019","journal-title":"Curr. Obes. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2023.115113_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s10020-019-0085-2","article-title":"miR-122 promotes hepatic lipogenesis via inhibiting the LKB1\/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease","volume":"25","author":"Long","year":"2019","journal-title":"Mol. Med"},{"key":"10.1016\/j.biopha.2023.115113_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1743-7075-11-35","article-title":"Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice","volume":"11","author":"Zhu","year":"2014","journal-title":"Nutr. Metab. (Lond. )"},{"issue":"8","key":"10.1016\/j.biopha.2023.115113_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183541","article-title":"Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats","volume":"12","author":"Ding","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2023.115113_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/13543784.2020.1668374","article-title":"GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)","volume":"29","author":"Alkhouri","year":"2020","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"4","key":"10.1016\/j.biopha.2023.115113_bib44","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/cbin.10915","article-title":"Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism","volume":"42","author":"Ke","year":"2018","journal-title":"Cell Biol. Int"},{"issue":"1","key":"10.1016\/j.biopha.2023.115113_bib45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cmet.2018.08.020","article-title":"Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma","volume":"29","author":"Lally","year":"2019","journal-title":"Cell Metab."},{"issue":"15","key":"10.1016\/j.biopha.2023.115113_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017247","article-title":"p53-Mediated Repression of the PGC1A (PPARG Coactivator 1\u03b1) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio-oncology","volume":"9","author":"Saleme","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"10.1016\/j.biopha.2023.115113_bib47","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.3390\/nu13082596","article-title":"Reduced Liver-Specific PGC1a Increases Susceptibility for Short-Term Diet-Induced Weight Gain in Male Mice","volume":"13","author":"Morris","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.biopha.2023.115113_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12944-016-0358-5","article-title":"Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice","volume":"15","author":"Wang","year":"2016","journal-title":"Lipids Health Dis."},{"issue":"3","key":"10.1016\/j.biopha.2023.115113_bib49","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/hep.23094","article-title":"Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis","volume":"50","author":"Fujita","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2023.115113_bib50","doi-asserted-by":"crossref","first-page":"4532482","DOI":"10.1155\/2020\/4532482","article-title":"Preventive effects of kaempferol on high-fat diet-induced obesity complications in C57BL\/6 mice","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.biopha.2023.115113_bib51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fmed.2020.00467","article-title":"Disturbances in cholesterol homeostasis and non-alcoholic fatty liver diseases","volume":"7","author":"Malhotra","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.biopha.2023.115113_bib52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3892\/ijmm.2012.1204","article-title":"Kaempferol suppresses lipid accumulation in macrophages through the downregulation of cluster of differentiation 36 and the upregulation of scavenger receptor class B type I and ATP-binding cassette transporters A1 and G1","volume":"31","author":"Li","year":"2013","journal-title":"Int J. Mol. Med"},{"issue":"11","key":"10.1016\/j.biopha.2023.115113_bib53","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/biomedicines8110524","article-title":"Cholesterol Efflux Capacity and Cardiovascular Disease: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study","volume":"8","author":"Ritsch","year":"2020","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.biopha.2023.115113_bib54","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/nu5020498","article-title":"Fat depots, free fatty acids, and dyslipidemia","volume":"5","author":"Ebbert","year":"2013","journal-title":"Nutrients"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223009046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223009046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:34:33Z","timestamp":1777880073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223009046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":54,"alternative-id":["S0753332223009046"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115113","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1\/AMPK signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115113"}}